Skip navigation
MedlinePlus Trusted Health Information for You U.S. National Library of MedicineNational Institutes of Health
Contact Us FAQs Site Map About MedlinePlus
español Home Health Topics Drug Information Medical Encyclopedia Dictionary News Directories Other Resources

 

Medical Encyclopedia

Other encyclopedia topics:  A-Ag  Ah-Ap  Aq-Az  B-Bk  Bl-Bz  C-Cg  Ch-Co  Cp-Cz  D-Di  Dj-Dz  E-Ep  Eq-Ez  F  G  H-Hf  Hg-Hz  I-In  Io-Iz  J  K  L-Ln  Lo-Lz  M-Mf  Mg-Mz  N  O  P-Pl  Pm-Pz  Q  R  S-Sh  Si-Sp  Sq-Sz  T-Tn  To-Tz  U  V  W  X  Y  Z  0-9 

Chronic lymphocytic leukemia (CLL)

Printer-friendly versionEmail this page to a friend
Contents of this page:

Illustrations

Bone marrow aspiration
Bone marrow aspiration
Auer rods
Auer rods
Chronic lymphocytic leukemia - microscopic view
Chronic lymphocytic leukemia - microscopic view
Antibodies
Antibodies

Alternative names    Return to top

CLL

Definition    Return to top

Chronic lymphocytic leukemia is a malignancy (cancer) of the white blood cells (lymphocytes) characterized by a slow, progressive increase of these cells in the blood and the bone marrow.

Causes, incidence, and risk factors    Return to top

Chronic lymphocytic leukemia (CLL) affects the B lymphocytes and causes immunosuppression, failure of the bone marrow, and invasion of malignant (cancerous) cells into organs.

Usually the symptoms develop gradually. The incidence is about 2 per 100,000 and increases with age (90% of cases are found in people over 50). Many cases are detected by routine blood tests in people with no symptoms. The cause of CLL is unknown. No relationship to radiation, carcinogenic chemicals or viruses has been determined. The disease is more common in Jewish people of Russian or East European descent, and is uncommon in Asia.

Symptoms    Return to top

Signs and tests    Return to top

This disease may also alter the results of serum protein electrophoresis.

Treatment    Return to top

Since early treatment does not improve survival, early-stage disease often requires no specific treatment, but close observation is important. Chemotherapy may be needed if a patient develops fatigue, anemia, thrombocytopenia, or enlarged lymph nodes that are troublesome.

The anti-cancer medicine (chemotherapy) used first is usually fludarabine. Other medicines that may be used in this disease include chlorambucil (Leukeran) and cyclophosphamide (Cytoxan).

The treatment of CLL is changing rapidly. Recently, several new drugs, including alemtuzumab (Campath) -- which is an antibody against the surface of CLL cells -- has been approved for treatment of patients with CLL who have failed fludarabine. Another antibody drug, rituximab (Rituxan), may also be used alone or in combination with traditional chemotherapy. Rarely, radiation may be used for enlarged lymph nodes. Blood transfusions or platelet transfusions may be required.

Support Groups    Return to top

The stress of illness may be eased by joining a support group whose members share common experiences and problems.

Expectations (prognosis)    Return to top

The prognosis depends on the stage of the disease. Half of patients diagnosed in the earliest stages of the disease live more than 12 years. On the other hand, if CLL has reached an advanced stage, about half of these patients die within 2 years.

Complications    Return to top

Calling your health care provider    Return to top

Call health care provider if you develop enlarged lymph nodes or unexplained fatigue, bruising, excessive sweating, or weight loss.

Update Date: 8/3/2004

Updated by: Marcia S. Brose, M.D., Ph.D., Assistant Professor, Hematology/Oncology, The University of Pennsylvania Cancer Center, Philadelphia, PA. Review provided by VeriMed Healthcare Network.

adam.com logo

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed physician should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. Copyright 2002 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.